デフォルト表紙
市場調査レポート
商品コード
347615

バイオアナリシス (生物分析) におけるラボオートメーションの世界市場 - 成長、動向、および予測

Lab Automation in Bioanalysis Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

出版日: | 発行: Mordor Intelligence Pvt Ltd | ページ情報: 英文 120 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.10円
バイオアナリシス (生物分析) におけるラボオートメーションの世界市場 - 成長、動向、および予測
出版日: 2021年01月01日
発行: Mordor Intelligence Pvt Ltd
ページ情報: 英文 120 Pages
納期: 2-3営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

当レポートは世界のバイオアナリシスにおけるラボオートメーション市場について調査しており、市場の機会や課題、投資分析、成長および阻害要因、提供・分析装置・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 イントロダクション

  • 調査の成果
  • 調査の仮定
  • 調査範囲

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 市場力学

  • 市場概況
  • 市場成長要因
  • 市場阻害要因
  • 産業バリューチェーン分析
  • ポーターのファイブフォース分析
    • サプライヤーの交渉力
    • バイヤー/消費者の交渉力
    • 新規参入の脅威
    • 代替製品の脅威
    • 業界内の競争
  • 技術スナップショット

第5章 市場セグメント

  • 提供別
    • 装置
    • ソフトウェア
  • 分析装置別
    • 生化学分析装置
    • 免疫ベースの分析装置
    • 血液分析装置
    • セルカウンター
    • 凝固計
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東およびアフリカ地域

第6章 競合情勢

  • 会社概要
    • Thermo Fisher Scientific Inc.
    • Agilent Technologies
    • Beckman Coulter Inc. (Danaher Corporation)
    • Hamilton Company
    • Hudson Robotics Inc.
    • Becton, Dickinson and Company
    • Siemens Healthineers AG
    • Tecan Group Ltd.
    • 株式会社島津製作所

第7章 投資分析

第8章 市場機会および将来動向

目次
Product Code: 50582

The lab automation in bioanalysis market was valued at USD 5.06 billion in 2020 and is expected to reach USD 7.10 billion by 2026, at a CAGR of 5.8% over the forecast period (2021 - 2026). Lab automation is required in bioanalysis applications, as manual and traditional handling can result in a corrupted or infected sample. The emergence of automated solutions, such as automated liquid handlers, automated plate handlers, and robotics, has eliminated the need for human intervention in bioanalysis laboratories by increasing accuracy and improving efficiency.

  • For clinical trials, it is sometimes imperative to monitor drug levels in subjects in real-time, which enables medical monitors and clinical investigators to adjust the dosing to meet the subject's needs and study requirements. Thus, clinical trials and diagnostics require bioanalysis technologies. Automated handling makes it easier to obtain error-free results. Owing to the rise in the number of clinical trials and studies and the growth in complexity, lab automation in bioanalysis is projected to experience significant demand.
  • Various aspects, such as growing reproducibility and accuracy, miniaturization in the process, progressing drug discovery, clinical diagnostics, and the large gap in workforce demand and supply, have driven the growth of the market across the world. Moreover, factors, such as technological innovations leading to device miniaturization and increased throughput and rising demand for personalized medicines, are significantly driving the market growth.
  • However, high capital requirements for setup will be a major hindrance to market growth.

Key Market Trends

Robotic Arms to be the Fastest Growing Equipment Segment

  • Robotic arms in lab automation are used for chemical analysis. Pharmaceutical companies are employing robots to move samples around the workspace for diagnosing chemical entities from the existing sample. Robotic arms are used for sample handling, coupled with new technologies, to eliminate errors.
  • The pharmaceutical industry has experienced increased use of robotic arms, as the synthesizing of samples with structural analysis can be done automatically. Robotic arms are used in applications, like biological and combinatorial chemistry for sample diagnosis, with automation increasing the market's standards.
  • Further, robotic arms also help in doing the mundane task in the laboratory set up saving time and energy of a human being doing that task. According to IFR, World Robotics 2018, sales of medical robots increased by 73% compared in 2016 to 2,931 units in 2017, accounting for a share of 2.7% of the total unit sales of professional service robots. The major reason identified for an increased sale has been the wide use in robotic surgery and laboratory automation in clinics.

North America to Hold Largest Market Share

  • A rise in the number of global clinical and pre-clinical studies has made the need for speedy analysis of samples imperative, making automation one of the key components contributing to the growth of the market.
  • Various aspects, such as growing reproducibility and accuracy, miniaturization in the process, progressing drug discovery, clinical diagnostics, and the large gap in workforce demand and supply, have driven the growth of the market across the world. Cost-effectiveness, owing to routine work, professional labor cost, and precise handling, is a variable that impacts the demand for these solutions.
  • Strict regulations by the US government and the FDA, the growing demand in the diagnostic market, and the increasing usage of discovery and research labs, owing to the rising presence of various diseases, such as cardiovascular diseases and neurological diseases in the region, have fueled the growth of the market. The US dominates the North American market and is the major revenue contributor in the region.

Competitive Landscape

The lab automation in bioanalysis market is consolidated. Major players have the maximum market share. Also, the players in the lab automation in bioanalysis market are increasingly competing against each other based on factors, such as product innovations and technological advances. Some of the key players include Thermo Fisher Scientific, Beckman Coulter (Danaher Corporation), Hudson Robotics, Becton Dickinson, Synchron Lab Automation, Agilent Technologies, Siemens Healthcare, Tecan Group Ltd, PerkinElmer, Bio-Rad, Roche Holding AG, Eppendorf AG, Shimadzu, and Aurora Biomed, among others.

  • May 2019 - Beckman Coulter, announced the latest addition to its automation portfolio. The DxA 5000 total laboratory automation solution has achieved European CE Mark and China Food and Drug Administration approval. In the healthcare environment, laboratories are highly focused on enhancing patient care, by driving faster turnaround time, delivering quality results, and improving laboratory operations. The DxA 5000 helps laboratories meet these challenges through a collection of patented innovations that deliver rapid and consistent turnaround time, provide a new level of comprehensive pre-analytical sample quality detection, and reduce the number of manual processing steps to significantly improve laboratory efficiency.
  • September 2018 - Tecan successfully completed the acquisition of NuGEN Technologies.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Demand for Personalized Medicines
    • 4.2.2 Technological Innovations Resulting in Improved Solutions
  • 4.3 Market Restraints
    • 4.3.1 High Capital Requirements for Setup
  • 4.4 Industry Value Chain Analysis
  • 4.5 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.5.1 Bargaining Power of Suppliers
    • 4.5.2 Bargaining Power of Buyers/Consumers
    • 4.5.3 Threat of New Entrants
    • 4.5.4 Threat of Substitute Products
    • 4.5.5 Intensity of Competitive Rivalry
  • 4.6 Technology Snapshot

5 MARKET SEGMENTATION

  • 5.1 By Offering
    • 5.1.1 Equipment
      • 5.1.1.1 Automated Liquid Handlers
      • 5.1.1.2 Automated Plate Handlers
      • 5.1.1.3 Robotic Arms
      • 5.1.1.4 AS/RS
      • 5.1.1.5 Vision Systems
    • 5.1.2 Software
  • 5.2 By Analyzers
    • 5.2.1 Biochemistry Analyzers
    • 5.2.2 Immuno-Based Analyzers
    • 5.2.3 Hematology Analyzers
    • 5.2.4 Cell Counters
    • 5.2.5 Coagulometers
  • 5.3 Geography
    • 5.3.1 North America
    • 5.3.2 Europe
    • 5.3.3 Asia-Pacific
    • 5.3.4 Latin America
    • 5.3.5 Middle East & Africa

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Thermo Fisher Scientific Inc.
    • 6.1.2 Agilent Technologies
    • 6.1.3 Beckman Coulter Inc. (Danaher Corporation)
    • 6.1.4 Hamilton Company
    • 6.1.5 Hudson Robotics Inc.
    • 6.1.6 Becton, Dickinson and Company
    • 6.1.7 Siemens Healthineers AG
    • 6.1.8 Tecan Group Ltd
    • 6.1.9 Shimadzu Corporation

7 INVESTMENT ANALYSIS

8 MARKET OPPORTUNITIES AND FUTURE TRENDS